U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07400263) titled 'Evaluation of an EpCAM-Targeted Radiotracer in Epithelial Tumors' on Feb. 03.
Brief Summary: The goal of this prospective, single-arm clinical trial is to evaluate the imaging performance and safety of an EpCAM-targeted radiotracer, [68Ga]Ga-PN-EpC1, in patients with epithelial tumors.
The main questions it aims to answer are:
* What is the sensitivity of [68Ga]Ga-PN-EpC1 PET/CT for detecting EpCAM-positive tumor lesions?
* How does the radiotracer uptake correlate with EpCAM expression assessed by immunohistochemistry?
* Is [68Ga]Ga-PN-EpC1 safe and well tolerated when administered for PET/CT imaging in patients with epithelial...